Faricimab appears to be effective after the failure of other treatment options.
Switch to faricimab in various retinal diseases: real-world data.
Eitan Kaplan … GIlad Allon
International ophthalmology · May 2026
Purpose
To evaluate the efficacy of faricimab in various retinal conditions in previously treated patients.
Methods
This study included patients who received at least three faricimab injections at a large medical center between April 2023 and October 2024, all of whom were not naive to treatment.
More results
Patients had previously received intravitreal injections of medications including bevacizumab, ranibizumab, aflibercept 2 mg, brolucizumab, triamcinolone, and Ozurdex.
Following treatment with faricimab, the proportion of eyes with no intraretinal or subretinal fluid increased across all retinal diseases.
More results
The average height of the pigment epithelium detachment (pigment epithelium detachment) decreased in cases of NVAMD and polypoidal choroidal vasculopathy.